Mechanisms of Interferon-Lambda Programming at the Innate-Adaptive Immune Interface for Protection Against Virus Infection

先天适应性免疫接口的干扰素-Lambda 编程机制,用于预防病毒感染

基本信息

  • 批准号:
    9973444
  • 负责人:
  • 金额:
    $ 16.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-03-09 至 2023-02-28
  • 项目状态:
    已结题

项目摘要

Project Summary. The innate-adaptive immune interface represents the site of action where components of both innate and adaptive immunity cross-engage each other to program the effector actions of the adaptive immune response. The actions of the innate-adaptive immune interface are considered essential for establishing protective immunity and immune memory against virus infection. Type III interferon (IFN-λ) is a cytokine that functions at the innate-adaptive immune interface and is critical for mediating innate immune protection at mucosal barriers. IFN-λ provides therapeutic benefit against Influenza A virus (IAV) infection, however how it operates within the innate-adaptive interface is not defined. We have utilized a murine model of IAV infection to study the contribution of IFN-λ in regulation of immunity at the innate-adaptive interface during respiratory virus infection. Our studies show Ifnlr1-/- mice have blunted effector CD8+ T cell responses compared to WT mice and exhibit reduced survival upon heterosubtypic IAV re-challenge. Analysis of dendritic cells (DCs) reveals that IFN-λ signaling directs CD103+ DC migration and function to develop optimal anti-viral CD8+ T cell responses. Further, preliminary bioinformatic analysis suggests IFN-λ is essential for control of an Il10 immunoregulatory network in DCs during IAV infection. Our observations reveal that IFN-λ bridges innate and adaptive immunity to direct DCs to program effective T cell immunity against IAV. We hypothesize IFN-λ signaling in DC regulates an IL-10 program critical for development of effective T cell memory for lasting immunity against IAV. Thus, the studies in this proposal aim to: 1) determine the contribution of IFN-λ to generation of memory CD4+ and CD8+ T cell responses and 2) elucidate IFN-λ regulation of IL-10 in programming DC functions. Results from these studies will define the role of IFN-λ at the innate-adaptive immune interface in programming effective immunity against IAV infection and inform IFN-λ-based vaccine and immune therapy strategies to prevent and limit infection. !
项目摘要。先天适应性免疫界面代表了免疫系统的组成部分的作用部位。 先天性免疫和适应性免疫都相互交叉参与,以编程适应性免疫的效应器动作。 免疫反应先天适应性免疫界面的作用被认为是必不可少的, 建立针对病毒感染的保护性免疫和免疫记忆。III型干扰素(IFN-λ)是一种 一种在先天-适应性免疫界面起作用并对介导先天免疫至关重要的细胞因子 保护粘膜屏障。IFN-λ提供针对甲型流感病毒(IAV)感染的治疗益处, 然而,没有定义它如何在固有自适应接口内操作。我们利用了一种小鼠模型, IAV感染,研究IFN-λ在先天适应性界面免疫调节中的作用, 呼吸道病毒感染我们的研究表明,Ifnlr 1-/-小鼠具有钝化的效应CD 8 + T细胞应答 与WT小鼠相比,在异亚型IAV再攻击时表现出降低的存活率。枝晶分析 细胞(DC)的研究表明,IFN-λ信号传导指导CD 103 + DC迁移和功能,以开发最佳的抗病毒药物, CD 8 + T细胞应答。此外,初步的生物信息学分析表明,IFN-λ对于控制 IAV感染过程中DC中的IL 10免疫调节网络我们的观察表明IFN-λ与先天性 和获得性免疫以指导DC编程针对IAV的有效T细胞免疫。我们假设IFN-λ DC中的信号传导调节IL-10程序,该程序对于有效T细胞记忆的发展至关重要, 免疫IAV。因此,本提案中的研究旨在:1)确定IFN-λ对 记忆性CD 4+和CD 8 + T细胞应答的产生和2)阐明IFN-λ对IL-10的调节, 编程DC功能。这些研究的结果将确定IFN-λ在先天适应性 在编程针对IAV感染有效免疫中的免疫界面和基于IFN-λ的疫苗, 免疫治疗策略,以防止和限制感染。 !

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Emily Ann Hemann其他文献

Emily Ann Hemann的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Emily Ann Hemann', 18)}}的其他基金

RIG-I-like receptor regulation of pulmonary inflammation and homeostasis
RIG-I 样受体对肺部炎症和稳态的调节
  • 批准号:
    10711053
  • 财政年份:
    2023
  • 资助金额:
    $ 16.07万
  • 项目类别:
NON-CANONICAL MECHANISMS FOR INTERFERON-LAMBDA REGULATION OF SARS-COV-2 INFECTION
干扰素-Lambda 调节 SARS-COV-2 感染的非典型机制
  • 批准号:
    10574001
  • 财政年份:
    2023
  • 资助金额:
    $ 16.07万
  • 项目类别:
Mechanisms of Interferon-Lambda Programming at the Innate-Adaptive Immune Interface for Protection Against Virus Infection
先天适应性免疫接口的干扰素-Lambda 编程机制,用于预防病毒感染
  • 批准号:
    10368914
  • 财政年份:
    2021
  • 资助金额:
    $ 16.07万
  • 项目类别:

相似海外基金

Characterizing the SARS-CoV-2 antibody response and associations with patient factors: Serological profiling of participants enrolled in the GENCOV study
描述 SARS-CoV-2 抗体反应及其与患者因素的关联:参与 GENCOV 研究的参与者的血清学分析
  • 批准号:
    495256
  • 财政年份:
    2023
  • 资助金额:
    $ 16.07万
  • 项目类别:
Understanding the human antibody response to a malaria transmission-blocking vaccine
了解人类抗体对疟疾传播阻断疫苗的反应
  • 批准号:
    MR/X009491/1
  • 财政年份:
    2023
  • 资助金额:
    $ 16.07万
  • 项目类别:
    Research Grant
Probing the role of peptidoglycan modification in the antibody response to Staphylococcus aureus
探讨肽聚糖修饰在金黄色葡萄球菌抗体反应中的作用
  • 批准号:
    10549646
  • 财政年份:
    2023
  • 资助金额:
    $ 16.07万
  • 项目类别:
Identification of the antigenic targets of the clonal antibody response to Clostridioides difficile infection
鉴定针对艰难梭菌感染的克隆抗体反应的抗原靶点
  • 批准号:
    10742376
  • 财政年份:
    2023
  • 资助金额:
    $ 16.07万
  • 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
  • 批准号:
    10688292
  • 财政年份:
    2022
  • 资助金额:
    $ 16.07万
  • 项目类别:
Molecular dissection of IgA antibody response by developing monoclonal IgA antibodies from nasal mucosa of mice
通过从小鼠鼻粘膜中开发单克隆 IgA 抗体对 IgA 抗体反应进行分子剖析
  • 批准号:
    22H02875
  • 财政年份:
    2022
  • 资助金额:
    $ 16.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
  • 批准号:
    10634694
  • 财政年份:
    2022
  • 资助金额:
    $ 16.07万
  • 项目类别:
Genetic, structural and functional profiling of the human antibody response to arenavirus infection
人类抗体对沙粒病毒感染反应的遗传、结构和功能分析
  • 批准号:
    10514498
  • 财政年份:
    2022
  • 资助金额:
    $ 16.07万
  • 项目类别:
Mapping the antibody response to Trypanosoma brucei variant surface glycoprotein
绘制布氏锥虫变异表面糖蛋白的抗体反应
  • 批准号:
    10527979
  • 财政年份:
    2022
  • 资助金额:
    $ 16.07万
  • 项目类别:
Factors related to antibody response of COVID-19 vaccines: with focusing on metabolomics
与 COVID-19 疫苗抗体反应相关的因素:重点关注代谢组学
  • 批准号:
    22H03334
  • 财政年份:
    2022
  • 资助金额:
    $ 16.07万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了